Skip to content

PET-imaging of two Vartumabs (F8scFv and C9scFv) in patients with solid tumors – a Phase 0 basket trial

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-513827-18-00
Acronym
VAR2-2024-CS01
Enrollment
32
Registered
2024-09-24
Start date
2024-11-29
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder carcinoma, chondrosarcoma or osteosarcoma, head and neck squamous cell carcinoma (HNSCC), lung carcinoma and glioblastoma., Multiple solid tumors including: colorectal carcinoma (CRC), oesophageal or gastric carcinoma, pancreatic carcinoma

Interventions

None listed

Sponsors

Var2 Pharmaceuticals ApS
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026